Synergistic 5′-methylthioadenosine combinations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 7, 2012
Grant Date -
Jan 20, 2011
app pub date -
Mar 18, 2009
filing date -
Mar 19, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to combinations of 5′-methylthioadenosine and glatiramer acetate, and to their use in the treatment of multiple sclerosis. In a particular embodiment, the present invention relates to a product comprising 5′-methylthioadenosine and glatiramer acetate as a combined preparation for the simultaneous, separate, or sequential use thereof for the prevention and/or treatment of multiple sclerosis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully